112 related articles for article (PubMed ID: 9518263)
1. Effects of conformationally restricted synthetic retinoids on ovarian tumor cell growth.
Wu S; Zhang D; Donigan A; Dawson MI; Soprano DR; Soprano KJ
J Cell Biochem; 1998 Mar; 68(3):378-88. PubMed ID: 9518263
[TBL] [Abstract][Full Text] [Related]
2. Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.
Muccio DD; Brouillette WJ; Alam M; Vaezi MF; Sani BP; Venepally P; Reddy L; Li E; Norris AW; Simpson-Herren L; Hill DL
J Med Chem; 1996 Sep; 39(19):3625-35. PubMed ID: 8809153
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis in ovarian carcinoma cells by AHPN/CD437 is mediated by retinoic acid receptors.
Holmes WF; Dawson MI; Soprano RD; Soprano KJ
J Cell Physiol; 2000 Oct; 185(1):61-7. PubMed ID: 10942519
[TBL] [Abstract][Full Text] [Related]
5. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
Schneider SM; Offterdinger M; Huber H; Grunt TW
Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091
[TBL] [Abstract][Full Text] [Related]
6. Critical role of both retinoid nuclear receptors and retinoid-X-receptors in mediating growth inhibition of ovarian cancer cells by all-trans retinoic acid.
Wu S; Zhang D; Zhang ZP; Soprano DR; Soprano KJ
Oncogene; 1998 Dec; 17(22):2839-49. PubMed ID: 9879990
[TBL] [Abstract][Full Text] [Related]
7. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
[TBL] [Abstract][Full Text] [Related]
8. Reduction of both RAR and RXR levels is required to maximally alter sensitivity of CA-OV3 ovarian tumor cells to growth suppression by all-trans-retinoic acid.
Wu S; Zhang ZP; Zhang D; Soprano DR; Soprano KJ
Exp Cell Res; 1997 Nov; 237(1):118-26. PubMed ID: 9417874
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways.
Defacque H; Sévilla C; Piquemal D; Rochette-Egly C; Marti J; Commes T
Leukemia; 1997 Feb; 11(2):221-7. PubMed ID: 9009084
[TBL] [Abstract][Full Text] [Related]
10. Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells.
Hembree JR; Agarwal C; Beard RL; Chandraratna RA; Eckert R
Cancer Res; 1996 Apr; 56(8):1794-9. PubMed ID: 8620495
[TBL] [Abstract][Full Text] [Related]
11. Nicotine modulates the effects of retinoids on growth inhibition and RAR beta expression in lung cancer cells.
Chen GQ; Lin B; Dawson MI; Zhang XK
Int J Cancer; 2002 May; 99(2):171-8. PubMed ID: 11979430
[TBL] [Abstract][Full Text] [Related]
12. Modulation of retinoic acid receptor function alters the growth inhibitory response of oral SCC cells to retinoids.
Le Q; Dawson MI; Soprano DR; Soprano KJ
Oncogene; 2000 Mar; 19(11):1457-65. PubMed ID: 10723137
[TBL] [Abstract][Full Text] [Related]
13. Effects of retinoid X receptor-selective ligands on proliferation of prostate cancer cells.
de Vos S; Dawson MI; Holden S; Le T; Wang A; Cho SK; Chen DL; Koeffler HP
Prostate; 1997 Jul; 32(2):115-21. PubMed ID: 9215399
[TBL] [Abstract][Full Text] [Related]
14. Regulation of RAR beta expression by RAR- and RXR-selective retinoids in human lung cancer cell lines: effect on growth inhibition and apoptosis induction.
Li Y; Dawson MI; Agadir A; Lee MO; Jong L; Hobbs PD; Zhang XK
Int J Cancer; 1998 Jan; 75(1):88-95. PubMed ID: 9426695
[TBL] [Abstract][Full Text] [Related]
15. RAR and RXR selective ligands cooperatively induce apoptosis and neuronal differentiation in P19 embryonal carcinoma cells.
Horn V; Minucci S; Ogryzko VV; Adamson ED; Howard BH; Levin AA; Ozato K
FASEB J; 1996 Jul; 10(9):1071-7. PubMed ID: 8801169
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of both RAR and RXR restores AP-1 repression in ovarian adenocarcinoma cells resistant to retinoic acid-dependent growth inhibition.
Soprano DR; Chen LX; Wu S; Donigan AM; Borghaei RC; Soprano KJ
Oncogene; 1996 Feb; 12(3):577-84. PubMed ID: 8637715
[TBL] [Abstract][Full Text] [Related]
17. Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.
Zacheis D; Dhar A; Lu S; Madler MM; Klucik J; Brown CW; Liu S; Clement F; Subramanian S; Weerasekare GM; Berlin KD; Gold MA; Houck JR; Fountain KR; Benbrook DM
J Med Chem; 1999 Oct; 42(21):4434-45. PubMed ID: 10543887
[TBL] [Abstract][Full Text] [Related]
18. Retinoid signalling and gene expression in neuroblastoma cells: RXR agonist and antagonist effects on CRABP-II and RARbeta expression.
Hewson QC; Lovat PE; Pearson AD; Redfern CP
J Cell Biochem; 2002; 87(3):284-91. PubMed ID: 12397610
[TBL] [Abstract][Full Text] [Related]
19. Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells.
Dawson MI; Chao WR; Pine P; Jong L; Hobbs PD; Rudd CK; Quick TC; Niles RM; Zhang XK; Lombardo A
Cancer Res; 1995 Oct; 55(19):4446-51. PubMed ID: 7671258
[TBL] [Abstract][Full Text] [Related]
20. Effects of retinoid treatment of rats on hepatic microsomal metabolism and cytochromes P450. Correlation between retinoic acid receptor/retinoid x receptor selectivity and effects on metabolic enzymes.
Howell SR; Shirley MA; Ulm EH
Drug Metab Dispos; 1998 Mar; 26(3):234-9. PubMed ID: 9492386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]